| Ticker Details |
|
Revolution Medicines, Inc.
|
| IPO Date: |
February 13, 2020 |
| Sector: |
Healthcare |
| Industry: |
Biotech |
| Market Cap: |
$19.69B |
| Activated in VL: |
True |
| Average Daily Range |
| Avg Daily Range: |
$0.86 | 2.63%
|
| Avg Daily Range (30 D): |
$1.51 | 1.44%
|
| Avg Daily Range (90 D): |
$1.56 | 1.93%
|
| Institutional Daily Volume |
| Avg Daily Volume: |
.97M |
| Avg Daily Volume (30 D): |
3M |
| Avg Daily Volume (90 D): |
2.51M |
| Trade Size |
| Avg Trade Size (Sh.): |
70 |
| Avg Trade Size (Sh.) (30 D): |
69 |
| Avg Trade Size (Sh.) (90 D): |
67 |
| Institutional Trades |
| Total Institutional Trades: |
5,589 |
| Avg Institutional Trade: |
$3.57M |
| Avg Institutional Trade (30 D): |
$6.66M |
| Avg Institutional Trade (90 D): |
$5.77M |
| Avg Institutional Trade Volume: |
.09M |
| Avg Institutional Trades (Per Day): |
3 |
| Market Closing Trades |
| Avg Closing Trade: |
$7.5M |
| Avg Closing Trade (30 D): |
$37.97M |
| Avg Closing Trade (90 D): |
$29.36M |
| Avg Closing Volume: |
192.02K |
|
|
| Financials |
| |
TTM |
Q3 2025 |
Q2 2025 |
|
Basic EPS
|
$-5.19
|
$-1.61
|
$-1.31
|
|
Diluted EPS
|
$-5.19
|
$-1.61
|
$-1.31
|
|
Revenue
|
$M
|
$M
|
$M
|
|
Gross Profit
|
|
|
|
|
Net Income / Loss
|
$-960.98M
|
$-305.21M
|
$-247.79M
|
|
Operating Income / Loss
|
$-1037.05M
|
$-315.27M
|
$-264.71M
|
|
Cost of Revenue
|
|
|
|
|
Net Cash Flow
|
$18.15M
|
$-184.05M
|
$69.1M
|
|
PE Ratio
|
|
|
|
|
|
|